Azora Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -52,025 | -2,001 | -1,885 | -1,764 |
EBIT | -52,025 | -2,001 | -1,885 | -1,764 |
Net Income | -51,989 | -2,022 | -1,996 | -1,793 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,362 | -1,612 | -1,324 | -1,833 |
Cash | 28,712 | 4,584 | 5,881 | 4,606 |
Basic Shares | 2,625 | 1,509 | 1,111 | 953 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -7,798 | -8,283 | -6,887 | -10,858 |
EBIT | -7,799 | -8,284 | -6,887 | -10,859 |
Net Income | -7,977 | -13,197 | -5,123 | -12,731 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,492 | -6,922 | -6,806 | -11,185 |
Cash | 5,881 | 3,750 | 2,827 | 4,001 |
Basic Shares | 1,111 | 258 | 66 | 42 |